Related Experiment Video
Updated: Jul 25, 2026
08:48
Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Fungal infections: a growing threat
D M Dixon1, M M McNeil, M L Cohen
1Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. dd24a@nih.gov
Public Health Reports (Washington, D.C. : 1974)
|May 1, 1996
Summary
Fungal diseases are emerging due to more immunocompromised individuals, including those with HIV and transplant recipients. Addressing this requires better surveillance, diagnostics, and antifungal resistance monitoring.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Public Health
Background:
- Rising numbers of immunocompromised individuals (e.g., HIV/AIDS, transplant recipients, chemotherapy patients, premature infants) are increasing susceptibility to fungal infections.
- Both opportunistic fungal pathogens (Candida, Aspergillus) and endemic fungi (Coccidioides, Histoplasma) pose risks to these vulnerable populations.
- Fungal infections contribute significantly to morbidity, mortality, and healthcare expenses.
Purpose of the Study:
- To highlight the growing threat of fungal diseases.
- To underscore the need for improved strategies to combat emerging fungal infections.
Main Methods:
- This study is a review and synthesis of current knowledge on fungal disease emergence.
- It analyzes the factors contributing to increased susceptibility in specific patient groups.
- It discusses the implications of these infections on public health and healthcare systems.
Main Results:
- The primary driver for the emergence and reemergence of fungal diseases is the expanding population of immunocompromised individuals.
- Immunocompromised patients are susceptible to a wide spectrum of fungal pathogens, including opportunistic and endemic species.
- High rates of illness, death, and healthcare costs are associated with these infections.
Conclusions:
- Combating the rise in fungal diseases necessitates enhanced surveillance systems.
- Development and implementation of rapid, noninvasive diagnostic tools are crucial.
- Monitoring antifungal resistance and investing in research for prevention and control are essential.
Related Concept Videos
01:29Fungal Group Zygomycota
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
01:28Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
01:28Fungal Phylum Ascomycota
Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...